Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
103.00    -1.50 (-1.44%)
Bid:
102.50
Ask:
102.80
Spread: 0.30 (0.293%)
Market Cap: £382.30m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Director/PDMR Shareholding

25 Jan 2023 07:00

RNS Number : 7509N
RWS Holdings PLC
25 January 2023
 

 

For immediate release 25 January 2023

RWS Holdings plc

Notification and public disclosure of transactions by PDMRs

RWS Holdings plc ("RWS"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that on 24 January 2023 options relating to ordinary shares ("Shares") of 1 penny each in the capital of the Company ("Options") were granted under the RWS Holdings plc Long Term Incentive Plan ("LTIP") to the following persons discharging managerial responsibilities ("PDMRs") as set out below:

PDMR

Position

No. of Shares under Option

Exercise Price per Share

Ian El-Mokadem

Chief Executive Officer

314,207

1p

Candida Davies

Chief Financial Officer

181,516

1p

Daniel Bennett

President, IP Services

72,100

1p

Emer Dolan

President, Enterprise Services

78,805

1p

Terry Doyle

Chief Information Officer

63,246

1p

Jon Hart

President, Regulated Industries

90,626

1p

Jane Hyde

General Counsel and Company Secretary

69,570

1p

Thomas Labarthe

President, Language Services and Technology

100,805

1p

Christopher Lewey

Group Corporate Development Director

56,635

1p

Jim McHugh

Chief People Officer

57,716

1p

Maria Schnell

Chief Language Officer

62,593

1p

In addition, Options over 1,400,791 Shares were granted to other senior managers at RWS with an exercise price of 1p each.

The extent to which the Options will vest will be dependent (with 50:50 weighting) on earnings per share ("EPS") targets set in relation to a reference three year measurement period ending with the financial year ending 30 September 2025 ("FY 2025") and RWS's total shareholder return ("TSR") over the same three year period relative to a comparator group (the constituents of the FTSE 250 Index (excluding investment trusts) as at the start of the measurement period).

No portion of the EPS element will vest unless EPS for the final year equates to a compound annual growth rate ("CAGR") in EPS of 4.1 per cent. over the measurement period, for which one-quarter of the EPS element will vest. Full vesting of the EPS element requires EPS for the final year equating to a CAGR in EPS of 10.1 per cent. or better over the measurement period.

No portion of the TSR element will vest unless the Company's TSR performance over the measurement period is at least median ranking, for which one-quarter of the TSR element will vest. Full vesting of the TSR element requires upper quartile ranking performance or better over the same period.

The performance conditions, which will be disclosed in detail in next year's Directors' Remuneration Report, provide for discretion to be retained by the Board's Remuneration Committee to adjust the level of vesting that would apply (including to nil vesting) if it considers this to be appropriate (for example to counter windfall gains or to have regard to underlying financial performance and/or the shareholder experience over the measurement period).

The Options have a normal vesting date on the third anniversary of the grant date and ordinarily will be forfeited in the event of cessation of employment ahead of the vesting date. The Options granted to Ian El-Mokadem and Candida Davies are each subject to a holding period condition under which any shares acquired under the Options (net of sales for tax and national insurance) must be retained until at least the fifth anniversary of the grant date.

Once vested, Options ordinarily will remain exercisable in respect of their vested shares until the tenth anniversary of the award's grant date.

For further information, please contact:

RWS Holdings plc 01753 480200

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

 

MHP (Financial PR advisor) rws@mhpc.com

Katie Hunt / Simon Hockridge 020 3128 8100

 

Numis (Nomad & Joint Broker) 020 7260 1000

Stuart Skinner / Kevin Cruickshank/Will Baunton

 

Berenberg (Joint Broker) 020 3207 7800

Ben Wright/Toby Flaux/ Alix Mecklenburg-Solodkoff

 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language. 

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers . Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 

For further information, please visit: www.rws.com.

The information set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Ian El-Mokadem

2. Candida Davies

3. Daniel Bennett

4. Emer Dolan

5. Terry Doyle

6. Jon Hart

7. Jane Hyde

8. Thomas Labarthe 

9. Christopher Lewey

10. Jim McHugh

11. Maria Schnell

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1. Chief Executive Officer

2. Chief Financial Officer

3. President, IP Services

4. President, Enterprise Services

5. Chief Information Officer

6. President, Regulated Industries

7. General Counsel and Company Secretary

8. President, Language Services and Technology

9. Group Corporate Development Director

10. Chief People Officer

11. Chief Language Officer

b)

 

Initial notification /Amendment

 

 

Initial Announcement

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

RWS Holdings plc

b)

 

LEI

 

 

213800YGBGTTSKUVK111

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

GB00BVFCZV34

Identification code

b)

 

Nature of the transaction

 

 

Grant of nominal cost option under the RWS Holdings plc Long Term Incentive Plan

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

7. Nil

8. Nil

9. Nil

10. Nil

11. Nil

1. 314,207

2. 181,516

3. 72,100

4. 78,805

5. 63,246

6. 90,626

7. 69,570

8. 100,805

9. 56,635

10. 57,716

11. 62,593

d)

 

Aggregated information

- Aggregated volume

1,147,819

 

- Price

Nil

e)

 

Date of the transaction

 

 

24 January 2023

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKQBPCBKDKDB
Date   Source Headline
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20249:00 amRNSPublication of Annual Report and Notice of AGM
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSNon-executive Director Resignation
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 202311:20 amRNSAIM Rule 17 Update
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSAppointment of Non-executive Directors
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.